TriSalus Life Earnings Estimate

TLSI Stock   4.67  0.07  1.48%   
By analyzing TriSalus Life's earnings estimates, investors can diagnose different trends across TriSalus Life's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for TriSalus Life Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
TriSalus Life is projected to generate -0.165 in earnings per share on the 30th of September 2025. TriSalus Life earnings estimates show analyst consensus about projected TriSalus Life Sciences EPS (Earning Per Share). It derives the highest and the lowest estimates based on TriSalus Life's historical volatility. Many public companies, such as TriSalus Life, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing TriSalus Life's earnings estimates, investors can diagnose different trends across TriSalus Life's analyst sentiment over time as well as compare current estimates against different timeframes. The current Gross Profit is estimated to decrease to about 16.1 M. The current Pretax Profit Margin is estimated to decrease to -1.07Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TriSalus Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

TriSalus Life Earnings per Share Projection vs Actual

About TriSalus Life Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of TriSalus Life earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current TriSalus Life estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as TriSalus Life fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-279.5 M-293.5 M
Earnings Yield(0.25)(0.26)
Price Earnings Ratio(4.00)(4.19)
Price Earnings To Growth Ratio 0.09  0.10 

Currently Active Assets on Macroaxis

When determining whether TriSalus Life Sciences is a strong investment it is important to analyze TriSalus Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact TriSalus Life's future performance. For an informed investment choice regarding TriSalus Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TriSalus Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.15)
Revenue Per Share
1.246
Quarterly Revenue Growth
0.523
Return On Assets
(0.53)
Return On Equity
(4.96)
The market value of TriSalus Life Sciences is measured differently than its book value, which is the value of TriSalus that is recorded on the company's balance sheet. Investors also form their own opinion of TriSalus Life's value that differs from its market value or its book value, called intrinsic value, which is TriSalus Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TriSalus Life's market value can be influenced by many factors that don't directly affect TriSalus Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TriSalus Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.